Articoli scritti

  • Variations of nighttime and daytime bladder capacity in patients with nocturia: implications for diagnosis and treatment. Presicce F, Puccini F, De Nunzio C, Melchionna A, Lombardo R, Tubaro A. J Urol 2019 Jan 23, doi: 10.1097/JU.0000000000000022. [Epub ahead of print] PMID:30681510
  • Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients’ quality of life. Zecca C, Riccitelli G, Disanto G, Singh A, Digesu A, Panicari L, Puccini F, Mattioli M, Tubaro A, Gobbi C. Eur J Neurol. 2016 Jul;23(7):1228-34. doi: 10.1111/ene.13010. PMID: 27120000
  • The pelvic floor muscle hyperalgesia (PFMH) scoring system: a new classification tool to assess women with chronic pelvic pain: multicentre pilot study of validity and reliability. Bhide AA, Puccini F, Bray R, Khullar V, Digesu GA. Eur J Obstet Gynecol Reprod Biol. 2015 Oct;193:111-3. doi: 10.1016/j.ejogrb.2015.07.008. Epub 2015 Jul 31. PMID: 26291685.
  • Sacral neuromodulation: an effective treatment for lower urinary tract symptoms in multiple sclerosis. Puccini F, Bhide A, Elneil S, Digesu GA. Int Urogynecol J. 2016 Mar;27(3):347-54. doi: 10.1007/s00192-015-2771-0. Epub 2015 Jul 9. PMID: 26156206.
  • The management of overactive bladder: percutaneous tibial nerve stimulation, sacral nerve stimulation, or botulinum toxin? Tubaro A, Puccini F, De Nunzio C. Curr Opin Urol. 2015 Jul;25(4):305-10. doi: 10.1097/MOU.0000000000000180. Review. PMID: 26049873.
  •  The FIGO assessment scoring system (FASS): a new holistic classification tool to assess women with pelvic floor dysfunction: validity and reliability. Digesu GA, Swift S, Puccini F, Manonai J, Khullar V, Fernando R, Ortiz OC, Salvatore S. Int Urogynecol J. 2015 Jun;26(6):859-64. doi: 10.1007/s00192-014-2604-6. Epub 2015 Jan 13. PMID: 25578870.
  • The evolving picture of lower urinary tract symptom management. Tubaro A, De Nunzio C, Puccini F, Presicce F. Eur Urol. 2015 Feb;67(2):271-2. doi: 10.1016/j.eururo.2014.10.016. Epub 2014 Oct 29. PMID: 25457016.
  • [5ARI and PSA: open questions.]. Tubaro A, Puccini F, De Nunzio C. Urologia. 2014 Sep 23;81(Suppl. 24):12-16. doi: 10.5301/uro.5000070. PMID: 25350562.
  • Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice. Zecca C, Digesu GA, Robshaw P, Puccini F, Khullar V, Tubaro A, Gobbi C. Eur J Neurol. 2014 Mar;21(3):506-11. doi: 10.1111/ene.12339. Epub 2014 Jan 3. PMID: 24387787.
  • Does the onset or bother of mixed urinary incontinence symptoms help in the urodynamic diagnosis? Digesu GA, Derpapas A, Hewett S, Tubaro A, Puccini F, Fernando R, Khullar V. Eur J Obstet Gynecol Reprod Biol. 2013 Dec;171(2):381-4. doi: 10.1016/j.ejogrb.2013.09.036. Epub 2013 Oct 10. PMID: 24207052.
  • The importance of cystoscopy and bladder biopsy in women with refractory overactive bladder: the urogynaecologist’s point of view? Digesu GA, Sadeghi P, Sharma S, Puccini F, Tubaro A, Fernando R, Khullar V. Eur J Obstet Gynecol Reprod Biol. 2013 Jul;169(2):408-11. doi: 10.1016/j.ejogrb.2013.05.027. Epub 2013 Jun 30. Erratum in: Eur J Obstet Gynecol Reprod Biol. 2014 Nov;182:265. Sadenghi, Peter [corrected to Sadeghi, Peter]. PMID: 23820140.
  • Editorial comment. Tubaro A, De Nunzio C, Puccini F. Urology. 2013 Aug;82(2):320; discussion 320. doi: 10.1016/j.urology.2013.02.078. Epub 2013 Jun 13. PMID: 23769117.
  • Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature. Bhide AA, Puccini F, Khullar V, Elneil S, Digesu GA. Int Urogynecol J. 2013 Sep;24(9):1429-34. doi: 10.1007/s00192-012-2015-5. Epub 2013 Jan 12. Review. PMID: 23314224.
  • The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review. Tubaro A, Puccini F, De Nunzio C, Digesu GA, Elneil S, Gobbi C, Khullar V. Curr Urol Rep. 2012 Oct;13(5):335-42. doi: 10.1007/s11934-012-0266-9. Review. PMID: 22886612.
  • The inhibition of cyclin B1 gene transcription in quiescent NIH3T3 cells is mediated by an E-box. Farina A, Gaetano C, Crescenzi M, Puccini F, Manni I, Sacchi A, Piaggio G. Oncogene. 1996 Sep 19;13(6):1287-96. PMID: 8808703.